Parent-Child Yoga for Congenital Heart Disease
Trial Summary
What is the purpose of this trial?
This trial is testing if parent-child yoga sessions can help improve attention in young children with congenital heart disease. The study involves children aged 4 to 6 and their parents. Yoga is believed to help these children focus better and reduce symptoms of ADHD. Yoga has been explored as a beneficial intervention for various health conditions, including heart disorders and pain management in children with sickle cell disease.
Will I have to stop taking my current medications?
If your child is taking ADHD medication, they will need to temporarily stop it at least 48 hours before each assessment. For other medications, the protocol does not specify any requirements.
What data supports the effectiveness of the treatment Parent-child yoga for children with congenital heart disease?
There is emerging evidence that parent-child yoga can improve attention and reduce ADHD symptoms in children, which may be beneficial for those with congenital heart disease who are at higher risk for attention issues. Additionally, exercise programs, similar to yoga, have shown positive effects on quality of life and psychosocial functioning in children with congenital heart disease.12345
Is parent-child yoga safe for children with congenital heart disease?
Parent-child yoga, as a form of physical activity, is generally considered safe for children with congenital heart disease when the activity is moderate and tailored to the child's condition. Encouraging physical activities, including yoga, can improve quality of life and should be supported, although the specific safety of parent-child yoga interventions has not been extensively studied.14567
How does the parent-child yoga treatment for congenital heart disease differ from other treatments?
The parent-child yoga treatment is unique because it focuses on improving attention and reducing ADHD symptoms in children with congenital heart disease through a non-drug, interactive approach involving both parents and children. Unlike traditional medical treatments, this intervention emphasizes mental and emotional well-being alongside physical health.158910
Eligibility Criteria
This trial is for children aged 4 to 6 with congenital heart disease who have had heart surgery and show poor attention skills. They must not be on ADHD medication or have severe developmental delays, physical handicaps that prevent yoga, or recent structured yoga experience.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Recruitment
Recruitment of parent-child dyads for the study
Treatment
Participants receive an 8-week parent-child yoga intervention
Follow-up
Participants are monitored for adherence and outcomes post-intervention
Treatment Details
Interventions
- Parent-child yoga (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Anne Gallagher
Lead Sponsor
Centre Universitaire de Santé McGill
Collaborator
Heart and Stroke Foundation of Canada
Collaborator